Αποτελέσματα Αναζήτησης
14 Δεκ 2020 · This review aimed to evaluate the characteristics of COVID-19 pneumonia in pediatric populations, beginning from its etiology and pathological mechanisms and closing with its clinical management.
31 Μαΐ 2023 · Most COVID-19 patients experience moderate symptoms and rapid recovery, but those with COPD can develop moderate to severe COVID-19-associated pneumonia, followed by COVID-19 acute respiratory distress syndrome—ARDS (CARDS).
12 Δεκ 2020 · Data on the epidemiology and outcomes of COVID-19 among patients with COPD are still being accumulated. Here, we review the distinct issues of whether COPD is associated with an increased risk of acquiring COVID-19, or an increased risk of worse outcomes with COVID-19.
Background. Few studies have examined the impact of Coronavirus disease 2019 (COVID-19) infection on children with chronic lung disease (CLD). Objective. To perform a systematic review and meta-analysis to determine the prevalence, risk factors for contracting COVID-19, and complications of COVID-19, in children with CLD. Methods.
1 Ιουν 2021 · This review summarizes the current knowledge of the clinical patterns, cellular pathophysiology, and epidemiology of COVID-19 respiratory disease in children with specific attention toward factors that account for the maturation-related differences in disease severity.
27 Οκτ 2023 · Multifaceted non-pharmaceutical interventions during the COVID-19 pandemic have not only reduced the transmission of SARS-CoV2, but have had an effect on the prevalence of other pathogens. This retrospective study aimed to compare and analyze the changes of respiratory pathogens in hospitalized children with community-acquired pneumonia. Methods.
5 Νοε 2020 · COPD patients are included in shielding strategies due to their susceptibility to virus-induced exacerbations, compromised pulmonary function and high prevalence of associated comorbidities. Using evidence from basic science and cohort studies, this review addresses key questions concerning COVID-19 and COPD.
